Powered by Blogger.
Showing posts with label suppression of medical research. Show all posts
Showing posts with label suppression of medical research. Show all posts

Pharmaceutical Industry "'Mobilised' an Army of Patient Groups to Lobby Against" Improving Clinical Research Integrity

thumbnail I had guessed that this sort of thing was going on all the time, but being kept very well hidden.  Now we have some more evidence. An artic...

A Call to Restore the Integrity of Clinical Research - but Will Anyone Heed it?

thumbnail Concerns about suppression and manipulation of clinical research to serve vested interests have finally gotten a little more mainstream. B...

A Condemnation of Suppression of Medical Research... by Ben Goldacre in the New York Times

thumbnail Amazingly, this topic now seems to be in the mainstream. The Goldacre Version in the New York Times in 2013 In his op-ed , Ben Goldacre intr...

Oh, the Prices we Pay ... for Questionable Drug Marketing to Enrich Corporate Insiders - the Case of Questcor's H P Acthar Revisited

thumbnail In 2007, we first discussed the case of the amazing pricing of H P Acthar, a very old drug of questionable usefulness, as an example of the...

What If the Institute of Medicine Wrote a Report and Nobody Followed it? - the Case of the Standards for Developing Trustworthy Guidelines

thumbnail For over 20 years, clinical practice guidelines (CPGs) have been touted to improve health care quality and control costs.  Enormous numbers ...

When Clinical Trials are Meant for Marketing, not Science

thumbnail The development of the randomized controlled clinical trial (RCT) was one of the major scientific advances in clinical medicine.  RCTs provi...

Back to the Future - Another Medical Device Company Accused of Hiding ICD Defects

thumbnail Suppression of data about defects in and failures of implantable cardiac defibrillators (ICDs) was one of the big issues we featured in the ...

Giant GSK Settlement Provides Reminder of the Pervasiveness of Stealth Marketing

thumbnail The latest  and biggest legal settlement involving health care to hit the news, that of GlaxoSmithKline (GSK) and the US government, has man...